We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

601788:SSEEverbright Securities Company Limited Class A Analysis

Data as of 2026-05-29 - not real-time

CN¥14.27

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Everbright Securities is trading at CNY 14.27, well below its 20‑day (CNY 14.93), 50‑day (CNY 15.21) and 200‑day (CNY 17.31) moving averages, signaling a bearish technical backdrop. The 14‑day RSI sits at 36.6 and the MACD histogram is negative, reinforcing weak momentum, while the price hovers just above the nearest support at CNY 13.99 and below the resistance at CNY 15.71. Volatility is elevated at roughly 21% over the past month, yet the stock’s beta of 0.28 indicates limited sensitivity to broader market moves, and the market’s “Extreme Greed” sentiment (fear‑greed index 93) contrasts with the stock’s price weakness.
Fundamentally, the firm delivered a robust 24.5% revenue growth and maintains high gross (47%) and operating (46%) margins, but returns are modest (ROE 5.6%). A debt‑to‑equity ratio of 153% raises leverage concerns, though the company’s cash pile (CNY 166.6 B) comfortably exceeds its debt (CNY 116.7 B). The dividend yield of 1.55% with a 27% payout ratio appears sustainable, and a discounted cash‑flow model suggests a fair value near CNY 79.7, implying the stock is significantly undervalued relative to its intrinsic potential.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish technical indicators (price below SMAs, negative MACD)
  • Proximity to support level at CNY 13.99
  • Attractive dividend yield of 1.55%

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth of 24.5% and high profit margins
  • Substantial undervaluation indicated by DCF fair value
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Net cash position (cash exceeds debt)
  • Consistent high margins and growth trajectory
  • Long‑term dividend sustainability and upside potential from valuation gap

Key Metrics & Analysis

Financial Health

Revenue Growth24.50%
Profit Margin36.36%
P/E Ratio17.8
ROE5.64%
ROA1.33%
Debt/Equity153.43
P/B Ratio1.1
Op. Cash FlowCN¥12.8B
Industry P/E16.5

Technical Analysis

TrendBearish
RSI36.6
SupportCN¥13.99
ResistanceCN¥15.71
MA 20CN¥14.93
MA 50CN¥15.21
MA 200CN¥17.31
MACDBearish
VolumeStable
Fear & Greed Index93.09

Valuation

Fair ValueCN¥79.67
GradeUndervalued
TypeGrowth
Dividend Yield1.55%

Risk Assessment

Beta0.28
Volatility21.26%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.